clinical trials, comparator clinical trials, goBalto, pharma research
0 Comment
Craig Morgan outlines why comparator trials are useful and provides points to consider to ensure the best outcome.
ASP, Fortive, infection, J&J, Johnson and Johnson, medical devices, pharma deal, sterilisation
0 Comment
Johnson & Johnson (J&J) has announced that Fortive Corp has made an offer of about $2.7 billion in cash for its Advanced Sterilisation Products (ASP) business.
autoimmune disease, FDA approval, Genentech, pemphigus vulgaris, PV, rare disease, Rituxan, Roche
0 Comment
The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.
Apple, health app, health records, health records app, healthkit, Jeff Williams COO Apple, medical records, patient records
0 Comment
Apple has announced that it will open up its Health Records application programming interface (API) to developers and researchers this autumn so that they can create an ecosystem of apps that use health record data to better manage medications, nutrition plans and diagnosed diseases.
Christian Schubert, innovation eco system, Oncology, pharma innovation, Rekha Paleyanda, Servier, Shire, US pharma
0 Comment
Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China.
AbbVie, immunology, JAK1, RA, Rheumatoid arthritis, Upadacitinib
0 Comment
AbbVie has reported positive top-line results for its oral JAK1-selective inhibitor in rheumatoid arthritis (RA), bringing it closer to a potential new early treatment option for patients.
breast cancer, cancer, cancer drug, HER2-positive breast cancer, Oncology, Perjeta
0 Comment
The European Commission (EC) has approved Roche’s Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast cancer (eBC) at high risk of recurrence.
AI, Babylon, digital health, doctor consultations, Health management, patient centricity, Samsung
0 Comment
Samsung has partnered with digital healthcare company Babylon to provide access to medical services at the touch of a button for UK users of compatible Galaxy mobile devices.
Bayer, cancer partnership, cancer research, Innovation, MD Anderson, novel targeted cancer treatments
0 Comment
Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.
